Pires, Carla Marques
Joy, George
Triantafyllou, Miltiadis
Monteiro, Ricardo Prista
Ferreira, Ana
Savvatis, Konstantinos
Lopes, Luis Rocha
Funding for this research was provided by:
British Heart Foundation clinical research training fellowship (FS/CRTF/21/2469)
Barts Charity project grant (MRC0281)
Medical Research Council UK Research and Innovation Clinical Academic Research Partnership award (MR/T005181/1)
Article History
Received: 21 August 2024
Accepted: 11 February 2025
First Online: 26 February 2025
Declarations
:
: Ethical approval for the study was given by the Research Ethics Committee (IRAS 227168) and met the criteria established by the Declaration of Helsinki []. All participants provided written informed consent.
: Non applicable.
: Dr Lopes has received speaker fees from BMS, Sanofi Genzyme and Alnylam and consulting fees from BMS and Novo Nordisk.
: Not applicable.